Acetyl-L-carnitine arginine amide prevents β 25-35-induced neurotoxicity in cerebellar granule cells

Neurochemical Research

Volumn 22, Issue 3, 1997, Pages 257-265

  Scorziello, A ^a,b   Meucci, O ^a   Calvani, M ^c   Schettini, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Sigma Tau SpA   (Italy)

Author keywords

25 35; acetyl L carnitine arginine amide; calcium ions; cerebellar granule cells; neuroprotection; neurotoxicity

Indexed keywords

ACETYLCARNITINE ARGININAMIDE; CALCIUM; LEVACECARNINE; ST 857; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; GRANULE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ACETYLCARNITINE; AMYLOID BETA-PROTEIN; ANIMALS; ARGININE; BASAL METABOLISM; CELLS, CULTURED; CEREBELLUM; DRUG EVALUATION, PRECLINICAL; GLUTAMIC ACID; HOMEOSTASIS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; VIDEO RECORDING;

ANIMALIA;

EID: 0031055293     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022430503520     Document Type: Article

References (36)

1. Selkoe, D. J. 1993. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:403-409.
2. Selkoe, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
3. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. 1992. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389.
4. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314.
5. Koh, J. Y., Yang, L. L., and Cotman, C. W. 1990. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:315-320.
6. Yankner, B. A., Duffy, L. K., and Kirshner, D. A. 1990. Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides. Science 250:279-282.
7. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687.
8. Goodman, Y., and Mattson, M. P. 1994. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide induced oxidative injury. Exp. Neurol. 128:1-12.
9. Mattson, M. P., Tommaselli, K. J., and Rydel, R. E. 1993. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:35-49.
10. Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smit-Swintosky, V., and Rydel, R. E. 1993b. β-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzeimer's disease. Trends Neurosci. 16:409-414.
11. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., and Butterfield, D. A. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91:3270-3274.
12. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M. P., and Carney, J. M. 1994. β-amyloid peptide free radical fragments initiates synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer disease. Biochem. Biophys. Res. Commun. 200:710-715.
13. Fritz, I. B., and Arrigoni-Martelli, E. 1993. Site of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharm. Sci. 14:355-360.
14. Monti, D., Troiano, L., Tropea, F., Grassilli, E., Cossarizza, A., Barozzi, D., Pelloni, M. C., Tamassia, M. G., Bellomo, G., and Franceschi, C. 1992. Apoptosis-programmed cell death: a role in the aging process? Am. J. Clin. Nutr. 55:1208S-1214S.
15. Cross, C. E., Halliwell, B., Borish, E. T., Pryor, W. A., Ames, B. N., Saul, R. L., McCord, J. M., and Hrman, D. 1987. Oxygen radicals and human disease. Ann. Intern. Med. 107:526-545.
16. Byrne. E., Dennet, X., and Trounce, I. 1991. Oxidative energy failure in post-mitotic cells: a major factor in senescence. Rev. Neurol. 147:532-53.
17. Benzi, G., and Moretti. A. 1995. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16: 661-674.
18. Ghirardi, O., Milano, S., Ramacci, M. T., and Angelucci, L. 1988. Effect of acetyl-L-carnitine chronic treatment on discrimination model in aged rats. Physiol. Behav. 44:769-773.
19. Spagnoli, A., Lucca, U., and Menasce, G. 1991. Long-term L-acetyl-carnitine treatment in Alzheimer's disease. Neurology 41: 1726-1732.
20. Westlund, K. N., Lu, Y., Werrbach-Perez, K., Hulsebosch, C. E., Morgan, B., Pizzo, D. P., Eisenberg, H. M., and Perez-Polo, J. R. 1992. Effects of nerve growth factor and acetyl-L-carnitine arginyl amide on the human neuronal line HCN-1A. Int. J. Dev. Neurosci. 10(5):361-73.
21. Taglialatela, G., Navarra, D., Olivi, A., Ramacci, M. T., Werrbach-Perez, K., Perez-Polo, J. R., and Angelucci, L. 1995. Neurite outgrowth in PC12 cells stimulated by acetyl-L-carnitine arginine amide. Neurochem. Res. 20:1-9.
22. Levi, G., Aloisi, F., Ciotti, M. T., and Gallo, V. 1984. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cells cultures. Brain Res. 290:77-86.
23. Scorziello, A., Meucci, O., Florio, T., Fattore, M., Forloni, G. L., Salmona, M., and Schettini, G. 1996. β 25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells. J. Neurochem. 66:1995-2003.
24. Soto, A. M., and Sonnenschein, C. 1985. The role of estrogens on the proliferation of human breast tumor cells (MCF-7) Steroid. Biochem. 23:87-94.
25. Hansen, M. B., Nielsen, S. E., and Berg, K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing. J. Immunol Meth. 119:203-210.
26. Galli, C., Meucci, O., Scorziello, A., Werge, T. M., Calissano, and P., Schettini, G. 1995. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15(2):1172-1179.
27. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. 1985. A new generation of Ca2+ indicators with greatly improve fluorescence properties. J. Biol. Chem. 260:3440-3450.
28. Forloni, G., Angeretti, N., and Smiroldo, S. 1994. Neuroprotective activity of acety-L-carnitine: studies in vitro J. Neurosci. Res. 37: 92-96.
29. Arispe, N., Rojas, E., and Pollard, B. 1993. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromthamine and aluminium. Proc. Natl. Acad. Sci. 90:567-571.
30. Simmons, M. A., and Schnaider, C. R. 1993. Amyloid β peptides act directly on single neurons. Neurosci. Lett. 150:133-136.
31. Coyle, J. T., and Puttfarcken, P. 1993. Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689-695.
32. Tritschler, H. J., Packer, L., and Medori, R. 1994. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem. Mol. Biol. Int. 34:169-181.
33. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
34. Lockhart, B. P., Benicourt, C., Jiunien, J. L., and Privat, A. 1994. Inhibitors of free radicals formation fail to attenuate direct β-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurose. Res. 39:494-505.
35. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:372-375.
36. Lindholm, D., Dechant, G., Heisenberg, C. P., and Thoenen, H. 1993. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5:1455-1464.